Literature DB >> 7809069

Ras activation of genes: Mob-1 as a model.

P Liang1, L Averboukh, W Zhu, A B Pardee.   

Abstract

The ras oncogenes function by indirectly controlling expression of a subset of yet-undefined genes that are crucial for cell growth and differentiation. In a differential display strategy, numerous genes were identified on the basis of their differential expression in rat embryo fibroblasts transformed by the cooperation of mutant Ha-ras and p53 genes. We demonstrate here that one such gene, designated mob-1, is a downstream target of the Ras signaling pathway. The 417-bp mob-1 promoter, which contains dual NF-kappa B and AP-1 binding sites, confers the Ras inducibility. Oncogenic Ras as well as serum growth factors that activate endogenous Ras can induce mob-1 expression, but with a fundamental difference in that the oncogenic induction is constitutive whereas the serum induction is transient. mob-1 encodes a small secretory protein with a high degree of homology to IP-10, a member of a proinflammatory cytokine family. These findings link chronic inflammatory response to constitutive ras activation and tumorigenesis. Mob-1 may serve as a secreted marker for oncogenic Ha-ras mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809069      PMCID: PMC45469          DOI: 10.1073/pnas.91.26.12515

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  New vectors for high level expression of recombinant proteins in bacteria.

Authors:  D J Hakes; J E Dixon
Journal:  Anal Biochem       Date:  1992-05-01       Impact factor: 3.365

2.  Increased proliferation of human synovial fibroblasts treated with recombinant immune interferon.

Authors:  C E Brinckerhoff; P M Guyre
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

Review 3.  Signaling by the cytokine receptor superfamily: JAKs and STATs.

Authors:  J N Ihle; B A Witthuhn; F W Quelle; K Yamamoto; W E Thierfelder; B Kreider; O Silvennoinen
Journal:  Trends Biochem Sci       Date:  1994-05       Impact factor: 13.807

4.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Isolation of a transforming sequence from a human bladder carcinoma cell line.

Authors:  C Shih; R A Weinberg
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

6.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.

Authors:  C W Castor; J W Miller; D A Walz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; J Lukás; A Rejthar; J Kovarík; C A Midgley; J V Gannon; D P Lane
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

9.  Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter.

Authors:  Y Ohmori; T A Hamilton
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

10.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.

Authors:  S A Moodie; B M Willumsen; M J Weber; A Wolfman
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  11 in total

1.  Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential.

Authors:  L Yu; F Hui-chen; Y Chen; R Zou; S Yan; L Chun-xiang; W Wu-ru; P Li
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

2.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Differential screening of gene expression difference enriched by differential display.

Authors:  H Zhang; R Zhang; P Liang
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

4.  Differential display using one-base anchored oligo-dT primers.

Authors:  P Liang; W Zhu; X Zhang; Z Guo; R P O'Connell; L Averboukh; F Wang; A B Pardee
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

5.  Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation.

Authors:  C Sauder; W Hallensleben; A Pagenstecher; S Schneckenburger; L Biro; D Pertlik; J Hausmann; M Suter; P Staeheli
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Presence of P210bcrabl is associated with decreased expression of a beta chemokine C10 gene in a P210bcrabl-positive myeloid leukemia cell line.

Authors:  C M Lane; X Y Guo; L H Macaluso; K C Yung; A B Deisseroth
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

7.  Intrinsic responses to Borna disease virus infection of the central nervous system.

Authors:  K Morimoto; D C Hooper; A Bornhorst; S Corisdeo; M Bette; Z F Fu; M K Schäfer; H Koprowski; E Weihe; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Authors:  Zahra Ahmadi; Mohammad Kazemi Arababadi; Gholamhossin Hassanshahi
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method.

Authors:  R S Alpan; S Sparvero; A B Pardee
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 10.  [Rheumatoid arthritis: new molecular and cellular aspects].

Authors:  O Distler; U Müller-Ladner; J Schölmerich; R E Gay; S Gay
Journal:  Med Klin (Munich)       Date:  1999-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.